CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net (loss)	$ (135,076)	$ (15,242)
Adjustments to reconcile net (loss) to net cash provided by operating activities:
Depreciation and amortization	368,266	77,335
Reduction in the carrying amount of right-of-use assets	10,463	4,240
Net foreign currency losses	3,711	5,765
Derivative Instruments Not Designated as Hedging Instruments, Gain	(10,821)	0
Stock-based compensation	64,020	1,345
Deferred income taxes	(156,046)	(11,848)
Provision for uncollectible receivables	3,944	852
Other non-cash operating activities	1,108	167
Changes in assets and liabilities:
Accounts receivable	(11,060)	(17,637)
Contract assets	(10,672)	(14,769)
Contract costs	(5,357)	0
Lease liabilities	(10,303)	(3,146)
Prepaid expenses, prepaid income taxes, and other assets	27,641	(662)
Unrealized Gain (Loss) on Derivatives	40,454	0
Accounts payable, accrued expenses, income taxes payable and other liabilities	(12,038)	(7,628)
Contract liabilities	17,416	1,349
Net cash provided by operating activities	185,650	20,121
Cash flows from investing activities:
Purchases of property, equipment and leasehold improvements	(4,515)	(3,831)
Payments for business acquisitions, net of cash acquired	(72,498)	(1,065)
Payments for equity method investments	(676)	0
Payments for capitalized computer software development costs	(347)	0
Purchases of other assets	1,000	287
Net cash used in investing activities	(68,215)	(5,183)
Cash flows from financing activities:
Issuance of shares of common stock	31,542	0
Payment of tax withholding obligations related to restricted stock	(14,406)	0
Deferred business acquisition payments	(1,363)	0
Repayments of amounts borrowed under term loan	(276,000)	0
Net transfers to Parent Company	(5,749)	(17,249)
Payments of debt issuance costs	(2,375)	0
Net cash (used in) financing activities	(268,351)	(17,249)
Effect of exchange rate changes on cash and cash equivalents	(12,073)	(986)
(Decrease) in cash and cash equivalents	(162,989)	(3,297)
Cash and cash equivalents, beginning of period	449,725	23,659
Cash and cash equivalents, end of period	286,736	20,362
Supplemental disclosure of non-cash activities:
Change in purchases of property, equipment and leasehold improvements included in accounts payable and accrued expenses	(1,307)	(71)
Lease liabilities arising from obtaining right-of-use assets	784	288
Supplemental disclosure of cash flow information:
Income taxes paid, net	64,840	49,374
Interest paid	14,345	590
Reconciliation to amounts within the unaudited consolidated balance sheets: [Abstract]
Payments for Purchase of Other Assets	(1,000)	(287)
Proceeds from Derivative Instrument, Investing Activities	$ 10,821	$ 0